DiToro D, Harbour SN, Bando JK, Benavides G, Witte S, Laufer VA, Moseley C, Singer JR, Frey B, Turner H, Bruning J, Darley-Usmar V, Gao M, Conover C, Hatton RD, Frank S, Colonna M, Weaver CT
In the cardiac magnetic resonance (CMR) sub-study of the SUMMIT trial, in comparison with the placebo, the treatment of obesity-related HFpEF with tirzepatide can lead to a reduction in LV mass and pericardiac adipose tissue
At Universal Weight Loss Clinic, we recognize that successful weight management with diabetes requires more than just calorie controlits about creating balanced eating habits that support healthy blood sugar levels while promoting gradual, sustainable weight loss
Some particularly cautious protocols extend initial phases to 4-6 weeks, especially in patients with medical complexity or those extremely concerned about side effects
Several scenarios warrant prompt medical consultation to ensure both maternal and infant safety
and reduces recovery times